1. Home
  2. Analysis
  3. Meropenem
  4. Sinus-bradycardia

Meropenem and Sinus bradycardia - a phase IV clinical study of FDA data

Summary:

Sinus bradycardia is reported as a side effect among people who take Meropenem (meropenem), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Acyclovir, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Sinus bradycardia when taking Meropenem. It is created by eHealthMe based on reports of 33,250 people who have side effects when taking Meropenem from the FDA, and is updated regularly.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

What is Sinus bradycardia?

Sinus bradycardia (an unusually slow heartbeat due to heart disease) is found to be associated with 901 drugs and 1,055 conditions by eHealthMe. Check the latest studies of Sinus bradycardia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

33,250 people reported to have side effects when taking Meropenem.
Among them, 26 people (0.08%) have Sinus bradycardia.

Could Meropenem cause Sinus bradycardia?

Among these 26 people:

How long have people been on Meropenem when they have Sinus bradycardia? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Sinus bradycardia when taking Meropenem? *

  • female: 52.38 %
  • male: 47.62 %

What is the age of people who have Sinus bradycardia when taking Meropenem? *

  • 0-1: 5.88 %
  • 2-9: 0.0 %
  • 10-19: 11.76 %
  • 20-29: 5.88 %
  • 30-39: 23.53 %
  • 40-49: 5.88 %
  • 50-59: 11.76 %
  • 60+: 35.29 %

What are other drugs people take besides Meropenem? *

  1. Prograf: 6 people, 23.08%
  2. Furosemide: 6 people, 23.08%
  3. Acyclovir: 6 people, 23.08%
  4. Methylprednisolone: 5 people, 19.23%
  5. Prednisolone Acetate: 4 people, 15.38%
  6. Prednisolone: 4 people, 15.38%
  7. Fluconazole: 4 people, 15.38%
  8. Vancomycin Hydrochloride: 4 people, 15.38%
  9. Ganciclovir: 4 people, 15.38%
  10. Digoxin: 4 people, 15.38%

What are other side effects people have besides Sinus bradycardia? *

  1. Depressed Level Of Consciousness: 6 people, 23.08%
  2. Cardiac Arrest: 5 people, 19.23%
  3. Hypotension (abnormally low blood pressure): 4 people, 15.38%
  4. Breathing - Slowed Or Stopped: 4 people, 15.38%
  5. Acute Circulatory Failure (shock): 4 people, 15.38%
  6. Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest)): 4 people, 15.38%
  7. Anuria (failure of the kidneys to produce urine): 4 people, 15.38%
  8. Weight Increased: 3 people, 11.54%
  9. Blood Calcium Increased: 3 people, 11.54%
  10. Metabolic Alkalosis (too much bicarbonate in the blood): 3 people, 11.54%

What are the existing conditions these people have? *

  1. Bone Marrow Conditioning Regimen: 3 people, 11.54%
  2. White Blood Cell Count Decreased: 2 people, 7.69%
  3. Iron Deficiency Anaemia: 2 people, 7.69%
  4. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 2 people, 7.69%
  5. Pneumonia Bacterial (pneumonia associated with bacterial infection): 1 person, 3.85%
  6. Pneumonia: 1 person, 3.85%
  7. Nausea And Vomiting: 1 person, 3.85%
  8. High Blood Pressure: 1 person, 3.85%
  9. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 3.85%
  10. Depression: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and have Sinus bradycardia?

- Check whether Sinus bradycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meropenem:

Sinus bradycardia treatments and more:

How severe was Sinus bradycardia and when was it recovered:

Expand to all the drugs that have ingredients of meropenem:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus bradycardia:

Browse all the conditions that are associated with Sinus bradycardia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.